longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Bristol Myers Squibb

BMY

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfileWeekly ReviewWeekly Review
LongbridgeAI

Current ValuationThe current P/E ratio is 13.46, within the reasonable range, cheaper than 65.31% of the time in the past 5 years, and the industry ranks 19/257, the industry Median -1.41.

13.46xP/E
$61.15Stock price
$4.54Earnings per share
13.46xP/E
Stock price$61.15Earnings per share$4.54

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
16.66x
Typical range
-13.62x–22.27x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0295887116

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
BMYUSBristol Myers Squibb
13.46x62.25%$124.91B
GSKUSGSK
15.72x6.56%$101.29B
UCBJYUSUCB S.A.
17.99x--$45.82B
HLNUSHaleon
18.49x2.04%$40.12B
OTSKYUSOtsuka Pharmaceutical
14.63x--$37.88B
ZTSUSZoetis
11.22x6.81%$29.59B
ALPMYUSAstellas Pharma
11.58x--$27.00B
JAZZUSJazz Pharma
16.21x349.11%$15.25B
OPHLYUSOno Pharmaceutical
15.25x--$7.43B
INDVUSIndivior Pharmaceuticals
11.90x126.83%$4.24B
OGNUSOrganon
17.25x211.11%$3.61B
SNPHYUSSanten Pharmaceutical
14.12x--$3.49B
HYPMYUSHypera S.A.
10.21x--$3.35B
HRMYUSHarmony Biosciences
13.00x45.48%$2.36B
PBHUSPrestige Brands
12.65x7.48%$2.18B
GTBIFUSGreen Thumb Industries Inc.
14.79x--$1.87B
ANIPUSANI Pharma
16.79x51.20%$1.67B
OMERUSOmeros
12.03x1,913.34%$1.50B
PAHCUSPhibro Animal Health
13.88x26.75%$1.38B
CRONUSCronos
17.90x902.68%$1.25B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.